The purpose of this study is to determine whether concentrations of the study drug
(evacetrapib) in the blood stream is the same or is different when the person is also taking
gemfibrozil (a drug used to lower lipid levels). Each participant will receive gemfibrozil
alone, evacetrapib alone, and both drugs in combination. There is no washout period between
doses. The safety of both of the study drugs given together will be evaluated. Information
about any side effects that may have occurred will also be collected. This study will last
approximately 36 days.